Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 1.00 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.81 |
| ▸ | ITK | Q08881 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.56 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.55 |
| ▸ | SUV39H1 | O43463 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16569005 | 1.00 | EHMT2 (1.00) | EHMT2EHMT1ITKKDM4EMEN1 | |
| SCHEMBL25302284 | 0.90 | EHMT2 (1.00) | EHMT2EHMT1ITKKDM4EMEN1 | |
| SCHEMBL17915519 | 0.87 | EHMT2 (0.83) | EHMT2EHMT1ITKKDM4EMEN1 | |
| SCHEMBL16463988 | 0.87 | EHMT2 (0.77) | EHMT2EHMT1ITKKDM4E | |
| SCHEMBL21437365 | 0.83 | EHMT2 (0.71) | EHMT2EHMT1ITKKDM4EADORA2A | |
| SCHEMBL8225590 | 0.80 | EHMT2 (0.66) | EHMT2EHMT1ITKADORA2AOPRK1 | |
| SCHEMBL1467481 | 0.78 | ADORA2A (0.80) | EHMT2ITKADORA2A | |
| SCHEMBL5318309 | 0.77 | HDAC6 (0.76) | EHMT2EHMT1KDM4ETP53 | |
| SCHEMBL24845522 | 0.76 | OPRK1 (0.71) | EHMT2ITKKDM4EMEN1TSHR | |
| SCHEMBL24845486 | 0.76 | OPRK1 (0.71) | EHMT2ITKKDM4EMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598549-A2 | METHODS AND COMPOSITIONS FOR T CELL DIFFERENTIATION | The Children's Medical Center Corporation (US) | 2025-08-13 | — | — | EP | claimed |
| CN-120053433-A | Application of BRD4770 in preparation of medicines for treating and/or preventing DOX-induced cardiomyopathy | 天津医科大学 | 2025-05-30 | — | — | CN | claimed |
| US-20250160275-A1 | COMPOUNDS FOR MODIFYING MEIOTIC RECOMBINATION AND METHODS RELATING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-05-22 | — | — | US | claimed |
| US-20250144056-A1 | ANTIMICROBIAL HOST DEFENSE PEPTIDE-INDUCING COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECH COLLEGES (US) | 2025-05-08 | — | — | US | claimed |
| WO-2025059442-A1 | MODULATING PLANT RESPONSES TO STRESS AND GROWTH WITH CHEMICALS | REMOTE EPIGENETICS INC. (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2024211130-A1 | METHODS FOR MODIFYING MEIOTIC RECOMBINATION IN PLANTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-10-10 | — | — | WO | claimed |
| WO-2024199144-A1 | NOVEL REAGENT FOR MITIGATING LNP TOXICITY | SHANGHAI MOYIN THERAPEUTICS CO., LTD. (CN) | 2024-10-03 | — | — | WO | claimed |
| EP-4423254-A1 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | Memorial Sloan Kettering Cancer Center (US) | 2024-09-04 | — | — | EP | claimed |
| US-20240279600-A1 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-08-22 | — | — | US | claimed |
| WO-2023076554-A9 | COMPOSITIONS AND METHODS FOR PROMOTING IN VITRO MATURATION OF CELLS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-07-11 | — | — | WO | claimed |
| CN-115397974-A | Stromal-free T cell differentiation from human pluripotent stem cells | 儿童医疗中心有限公司 | 2022-11-25 | — | — | CN | claimed |
| US-20220313782-A1 | METHODS AND COMPOSITIONS INVOLVING TERT ACTIVATING THERAPIES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-10-06 | — | — | US | claimed |
| WO-2022187682-A2 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2022-09-09 | — | — | WO | claimed |
| WO-2022179445-A1 | CHEMICAL MICROMOLECULE COMPOSITION FOR CHEMICALLY INDUCING FIBROBLASTS TO BE REPROGRAMMED INTO LUNG STEM CELLS, AND USE THEREOF | 海门雨霖细胞科技有限责任公司 | 2022-09-01 | — | — | WO | claimed |
| CN-114958716-A | Method for reprogramming fibroblast into lung stem cell by chemical induction | 中国人民解放军海军军医大学第三附属医院 | 2022-08-30 | — | — | CN | claimed |
| CN-114958726-A | Chemical micromolecule composition for reprogramming fibroblast into lung stem cell by chemical induction and application thereof | 海门雨霖细胞科技有限责任公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114344295-A | Application of inhibitor BRD4770 in preparing medicine for preventing and treating aortic dissection and pharmaceutical composition thereof | 华中科技大学同济医学院附属同济医院 | 2022-04-15 | — | — | CN | claimed |
| CN-114364392-A | Methods and compositions relating to TERT activation therapy | 德克萨斯大学系统董事会 | 2022-04-15 | — | — | CN | claimed |
| US-11298328-B2 | Sensorineural hair cell differentiation | MASSACHUSETTS EYE AND EAR INFIRMARY (US) | 2022-04-12 | — | — | US | claimed |
| EP-3962514-A1 | METHODS AND COMPOSITIONS INVOLVING TERT ACTIVATING THERAPIES | Board of Regents, The University of Texas System (US) | 2022-03-09 | — | — | EP | claimed |